AN ACT to amend Tennessee Code Annotated, Title 40, relative to the death penalty.
Summary
HB1022 amends Tennessee’s death penalty statute to expressly allow pharmaceutical fentanyl to be included in a lethal injection protocol used to carry out a sentence of death. The bill does not create a new death penalty method or change who may be sentenced to death; instead, it clarifies that fentanyl is a permissible drug option within the existing execution protocol framework.
The measure also sets an immediate effective date for rulemaking purposes, allowing the state to begin promulgating any necessary rules as soon as the bill becomes law, while the substantive change takes effect on July 1, 2025. In practical terms, the bill would affect the Department of Correction and any other state officials responsible for developing or administering execution procedures, as well as inmates subject to a death sentence.
Impact
The bill would amend Tennessee Code Annotated § 40-23-114 by adding a new subsection authorizing pharmaceutical fentanyl as part of lethal injection protocols. This would expand the list of drugs that may be used in executions under state law and could affect how the state drafts, updates, and defends its execution procedures. It does not alter the underlying death penalty statute itself, but it does provide explicit statutory support for one specific execution drug option.
Sentiment
Because there are no committee transcripts or recorded votes provided, there is no direct evidence of legislative debate or public sentiment in the supplied materials. Based on the bill text alone, the measure appears to be a technical but substantively significant change aimed at preserving or expanding the state’s ability to carry out death sentences through lethal injection. Any broader sentiment would likely track the larger, often polarized debate over capital punishment and execution methods.
Contention
The main point of contention is likely the use of fentanyl in executions, which raises ethical, legal, and practical concerns for opponents of the death penalty and for those worried about drug sourcing, pain, and constitutional challenges. Supporters would likely view the bill as a necessary clarification or tool for maintaining an available execution protocol. No specific lawmakers or stakeholder groups are identified in the provided record, but the issue would typically divide death penalty proponents from abolitionists and anti-execution advocates.